SCHEMBL6804286

SCHEMBL6804286

Cc1cccc2c(=O)n([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)ccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY2 P41231 3/20 0.64
SLC5A2 P31639 3/20 0.54
SLC28A1 O00337 1/20 0.52
SLC28A2 O43868 1/20 0.52
SLC29A1 Q99808 1/20 0.52
SLC28A3 Q9HAS3 1/20 0.52
LMNA P02545 1/20 0.50
THRB P10828 1/20 0.50
MTOR P42345 1/20 0.50
MDM2 Q00987 1/20 0.50
NCOA1 Q15788 1/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
MAPT P10636 1/20 0.50
CDA P32320 1/20 0.50
ADK P55263 1/20 0.47
SLC5A1 P13866 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6804279 1.00 P2RY2 (0.64) P2RY2SLC5A2SLC28A1SLC28A2SLC29A1
Benzoic Acid SCHEMBL6797862 0.92 P2RY2 (0.56) P2RY2SLC5A2SLC28A1SLC28A2SLC29A1
SCHEMBL6799149 0.85 P2RY2 (0.62) P2RY2SLC5A2SLC28A1SLC28A2SLC29A1
SCHEMBL6799153 0.85 P2RY2 (0.62) P2RY2SLC5A2SLC28A1SLC28A2SLC29A1
SCHEMBL6798844 0.83 P2RY2 (0.82) P2RY2
SCHEMBL6792832 0.82 P2RY2 (0.64) P2RY2SLC5A2SLC28A1SLC28A2SLC29A1
SCHEMBL6792828 0.82 P2RY2 (0.64) P2RY2SLC5A2SLC28A1SLC28A2SLC29A1
SCHEMBL6795846 0.81 P2RY2 (0.62) P2RY2SLC5A2SLC28A1SLC28A2SLC29A1
SCHEMBL6795708 0.81 P2RY2 (0.62) P2RY2SLC5A2SLC28A1SLC28A2SLC29A1
Phosphoric Acid SCHEMBL6798848 0.80 P2RY2 (0.60) P2RY2LMNAMAPTTSHRPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040122223-A1 Non-natural nucleotides and dinucleotides CELLTECH R & D LIMITED (GB) 2004-06-24 US disclosed
EP-1368366-A1 NON-NATURAL NUCLEOTIDES AND DINUCLEOTIDES Celltech R & D Limited (GB) 2003-12-10 EP disclosed
WO-2002062816-A1 NON-NATURAL NUCLEOTIDES AND DINUCLEOTIDES CELLTECH R & D LIMITED (GB) 2002-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122223-A1 Non-natural nucleotides and dinucleotides P2RY1, P2RY11, P2RY13 P2RY2 8/4885SLC5A2 92/4885SLC28A1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.